The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.
The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.
The Department of Health and Human Services (HHS) issued a statement on Sunday:
The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.
Supreme Court blocks California ban on notifying students’ parents about gender transitions
Cornyn wants to work with Trump to fix ‘broken’ immigration system if reelected
BREAKING: US Embassy in Riyadh, Saudi Arabia Hit by Multiple Iranian Drones
Markets Handle Iran Strikes Brilliantly as S&P 500 Has Biggest Intraday Recovery in 5 Months Finishing Positive for the Day
Trump sends official notification to Congress on strikes against Iran
Virginia Mom Allegedly Murdered by Illegal Alien with 30 Priors Only Weeks After Dem Governor Blocks ICE Cooperation
Department of Education Honors Charlie Kirk with Banner as Part of America’s 250th Birthday Celebration: ‘Heroes in American Education’
Musk, xAI tout newest Grok update as only ‘non-woke’ platform: ‘Doesn’t equivocate”
Trump admin warned lawmakers Israel was ‘determined to act with or without us’ before massive Iran strikes
Tarot influencer’s claims in Idaho college murders case spark courtroom reckoning
New Jersey-bound United flight makes emergency landing at LAX after engine fire
What We Know About the African and Extremely Likely Jihadist Mass Shooter in Austin
Radical US mosques honor Iran’s Supreme Leader’s ‘martyrdom’ with memorial services, eulogy: ‘Our leader’
Bill Clinton reveals Trump ‘never said anything’ linking himself to Epstein’s crimes
WWII Hero Awarded Medal of Honor for Refusing to ID Jewish Americans While at Gunpoint: ‘We Are All Jews’
HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”
Earlier, the French government had approved similar drugs to treat the virus.
Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”
Supreme Court blocks California ban on notifying students’ parents about gender transitions
Cornyn wants to work with Trump to fix ‘broken’ immigration system if reelected
BREAKING: US Embassy in Riyadh, Saudi Arabia Hit by Multiple Iranian Drones
Markets Handle Iran Strikes Brilliantly as S&P 500 Has Biggest Intraday Recovery in 5 Months Finishing Positive for the Day
Trump sends official notification to Congress on strikes against Iran
Virginia Mom Allegedly Murdered by Illegal Alien with 30 Priors Only Weeks After Dem Governor Blocks ICE Cooperation
Department of Education Honors Charlie Kirk with Banner as Part of America’s 250th Birthday Celebration: ‘Heroes in American Education’
Musk, xAI tout newest Grok update as only ‘non-woke’ platform: ‘Doesn’t equivocate”
Trump admin warned lawmakers Israel was ‘determined to act with or without us’ before massive Iran strikes
Tarot influencer’s claims in Idaho college murders case spark courtroom reckoning
New Jersey-bound United flight makes emergency landing at LAX after engine fire
What We Know About the African and Extremely Likely Jihadist Mass Shooter in Austin
Radical US mosques honor Iran’s Supreme Leader’s ‘martyrdom’ with memorial services, eulogy: ‘Our leader’
Bill Clinton reveals Trump ‘never said anything’ linking himself to Epstein’s crimes
WWII Hero Awarded Medal of Honor for Refusing to ID Jewish Americans While at Gunpoint: ‘We Are All Jews’
President Donald Trump has suggested that hydroxychloroquine could be effective, and has encouraged further study. His interest in the drug has prompted pushback from the media.
NBC News’ Peter Alexander accused the president last week of giving Americans “false hope,” and Politico’s Dan Diamond reported Sunday that the FDA decision came despite “scant evidence,” adding that “[c]areer scientists have been skeptical of the effort.”
Story cited here.
